Xiaogang Xu
- Molecular Medicine top 0.1%
- Epidemiology top 5%
- Molecular Biology top 10%
- Infectious Diseases top 2%
- Endocrinology top 0.5%
- Topics
- Antibiotic Resistance in Bacteria (63 papers)Antimicrobial Resistance in Staphylococcus (31 papers)Antibiotics Pharmacokinetics and Efficacy (21 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Xiaogang Xu
114 papers receiving 3.0k citations
Peers
Comparison fields: 5 of 110
- Molecular Medicine 1.7k
- Epidemiology 746
- Molecular Biology 724
- Infectious Diseases 719
- Endocrinology 682
Countries citing papers authored by Xiaogang Xu
This map shows the geographic impact of Xiaogang Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaogang Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaogang Xu more than expected).
Fields of papers citing papers by Xiaogang Xu
This network shows the impact of papers produced by Xiaogang Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaogang Xu. The network helps show where Xiaogang Xu may publish in the future.
Co-authorship network of co-authors of Xiaogang Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaogang Xu. A scholar is included among the top collaborators of Xiaogang Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaogang Xu. Xiaogang Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 12 | |
| 3 | 1 | |
| 4 | 16 | |
| 5 | 16 | |
| 6 | 39 | |
| 7 | 13 | |
| 8 | 8 | |
| 9 | 65 | |
| 10 | 39 | |
| 11 | 12 | |
| 12 | 5 | |
| 13 | 36 | |
| 14 | 39 | |
| 15 | 10 | |
| 16 | 5 | |
| 17 | 29 | |
| 18 | 270 | |
| 19 | 41 | |
| 20 | 5 |
About Xiaogang Xu
Xiaogang Xu is a scholar working on Molecular Medicine, Endocrinology and Microbiology, having authored 117 papers that have together received 3.0k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (63 papers), Antimicrobial Resistance in Staphylococcus (31 papers) and Antibiotics Pharmacokinetics and Efficacy (21 papers). The work is most often cited by research in Molecular Medicine (1.7k citations), Endocrinology (682 citations) and Applied Microbiology and Biotechnology (169 citations). Xiaogang Xu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Minggui Wang, Qinglan Guo, Fupin Hu, Demei Zhu, Xinyu Ye, Yan Guo, Shi Wu, Baixing Ding, Minghua Wang and David C. Hooper. Their work appears in journals such as PLoS ONE, Analytical Chemistry and Clinical Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.